LexDanaLexDanabeta
Inventor

ARTHUR KLUGE

Inventor
US

Overview

4→
Patents
2023–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes23%
C07BGeneral methods of organic chemistry8%
C07CAcyclic or carbocyclic compounds8%
PatentTitleYear
12,492,206Salts of R-ketorolac202512,071,433HMOX1 inducers202411,993,585Poly-ADP ribose polymerase (PARP) inhibitors202411,578,052PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof2023

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2023–2024Patents assigned to MITOBRIDGE INC (2)· patent assignee history
2023Patents assigned to SALK INST BIOLOGICAL STUDIES (1)· patent assignee history
2023–2025Based in US· patent location history
2024Patents assigned to ASTELLAS ENG SMALL MOLECULES US INCORPORATED (1)· patent assignee history
2025Patents assigned to UNM RAINFOREST INNOVATIONS (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MITOBRIDGE INC22023–2024
ASTELLAS ENG SMALL MOLECULES US INCORPORATED12024
SALK INST BIOLOGICAL STUDIES12023
UNM RAINFOREST INNOVATIONS12025
Locations
LocationPatentsSpan
US42023–2025